KaNDy Therapeutics logo

KaNDy Therapeutics

KaNDy Therapeutics is a clinical-stage company focused on optimising the potential of NT-814 in the treatment of common, chronic debilitating female sex-hormone related conditions, with an initial focus on symptoms of the menopause.

1

Funding Rounds

$32.5m

Money raised

Overview

KaNDy Therapeutics is a clinical-stage company focused on optimising the potential of NT-814 in the treatment of common, chronic debilitating female sex-hormone related conditions, with an initial focus on symptoms of the menopause.

Industries

KaNDy Therapeutics is active in the following industries: